文献速递腹部US

非肝硬化肝内组织学证实的肝细胞癌的超声造影特征:一项多中心研究

Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study.
PubMed 文献 · Ultrasound Med Biol · 2022-06-14

该回顾性多中心研究分析了8家医疗机构96例非肝硬化肝内组织学证实肝细胞癌的超声造影(SonoVue)特征,由两名超声专家依据世界超声医学与生物学联合会指南标准达成共识。病灶平均大小60.3±37.8 mm,多数B模式超声表现为不均匀但以低回声为主(64.5%,62/96),边界不清、形态不规则;动脉期多数呈不均匀高增强(78.1%,75/96),28.1%(27/96)出现早期廓清(<60 s),所有病灶晚期均廓清并呈低增强。作者结论认为非肝硬化肝细胞癌超声造影表现与肝硬化肝细胞癌不同,更类似肝转移瘤。

要点

  • 非肝硬化肝细胞癌超声造影典型表现为动脉期高增强、门静脉期相对快速廓清。
  • 本组28.1%(27/96)病灶早期廓清(<60 s),所有病灶晚期均廓清呈低增强。
  • B模式超声多数病灶不均匀、以低回声为主(64.5%,62/96),边界不清、形态不规则。

核心结论

  • 非肝硬化肝细胞癌超声造影特征通常包括动脉期高增强和门静脉期相对快速廓清,与肝硬化肝细胞癌不同,更类似肝转移瘤。

研究设计与样本

  • 回顾性多中心研究,纳入8家医疗机构96例非肝硬化肝内组织学证实肝细胞癌患者,分析SonoVue增强超声造影特征,由两名超声专家依据世界超声医学与生物学联合会指南标准达成共识。

关键影像表现/征象

  • 多数病灶B模式超声呈不均匀但以低回声为主(64.5%,62/96),边界不清、形态不规则。
  • 动脉期多数病灶呈不均匀高增强(78.1%,75/96),与周围肝实质相比。
  • 28.1%(27/96)病灶出现早期廓清(<60 s)。
  • 所有病灶晚期均廓清并呈低增强。

诊断标准与关键数值

  • 两名超声专家依据世界超声医学与生物学联合会指南标准评估超声造影增强模式并达成共识。
  • 本组病灶平均大小60.3±37.8 mm(均值±标准差)。

临床应用与阅片要点

  • 阅片时注意非肝硬化肝细胞癌动脉期可呈不均匀高增强,而非均匀高增强。
  • 非肝硬化肝细胞癌可出现早期廓清(<60 s),晚期均廓清并低增强,表现更类似肝转移瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Current literature on the role of contrast-enhanced ultrasound (CEUS) in the diagnosis of hepatocellular carcinoma (HCC) in non-cirrhotic patients is limited. The aim of this retrospective multicenter study was to analyze CEUS features of histologically proven HCC in patients with non-cirrhotic liver. In this multicenter study, 96 patients from eight medical institutions with histologically proven HCC lesions in non-cirrhotic liver were retrospectively reviewed regarding SonoVue-enhanced CEUS features. Two ultrasound experts assessed the CEUS enhancement pattern and came to a consensus using the World Federation of Societies for Ultrasound in Medicine and Biology guideline criteria. The mean size of HCC lesions included was 60.3 ± 37.8 mm (mean ± standard deviation). Most of the lesions were heterogeneous but predominantly hypo-echoic on B-mode ultrasound (64.5%, 62/96), with ill-defined margins and irregular shapes. During the arterial phase of CEUS, most of the HCC lesions in non-cirrhotic liver exhibited heterogeneous hyperenhancement (78.1%, 75/96) compared with the surrounding liver parenchyma. Almost 30% of HCC lesions (28.1%, 27/96) exhibited early wash-out (<60 s). All lesions exhibited wash-out and hypo-enhancement in the late phase. CEUS features of HCC lesions in non-cirrhotic patients typically include hyperenhancement in the arterial phase and relatively rapid wash-out in the portal venous phase, which is different from HCC in cirrhotic livers and more similar to liver metastasis.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Dong, Wang, Lee, et al. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study. Ultrasound Med Biol. 2022. PMID: 35710501. doi:10.1016/j.ultrasmedbio.2022.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。